Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States

Aigner, 2007, The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity, Oncogene, 26, 6979, 10.1038/sj.onc.1210508 Barbie, 2009, Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1, Nature, 462, 108, 10.1038/nature08460 Barbie, 2014, Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth, J. Clin. Invest., 124, 5411, 10.1172/JCI75661 Barretina, 2012, The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, 483, 603, 10.1038/nature11003 Bild, 2006, Oncogenic pathway signatures in human cancers as a guide to targeted therapies, Nature, 439, 353, 10.1038/nature04296 Brunet, 2004, Metagenes and molecular pattern discovery using matrix factorization, Proc. Natl. Acad. Sci. USA, 101, 4164, 10.1073/pnas.0308531101 Chamorro, 2005, FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development, EMBO J., 24, 73, 10.1038/sj.emboj.7600460 Chang, 2009, A genomic strategy to elucidate modules of oncogenic pathway signaling networks, Mol. Cell, 34, 104, 10.1016/j.molcel.2009.02.030 Cheung, 2011, Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer, Proc. Natl. Acad. Sci. USA, 108, 12372, 10.1073/pnas.1109363108 Cichocki, 2008, 142 Cowley, 2014, Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies, Sci. Data, 1, 140035, 10.1038/sdata.2014.35 Dawson, 2012, Cancer epigenetics: from mechanism to therapy, Cell, 150, 12, 10.1016/j.cell.2012.06.013 De Raedt, 2014, PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies, Nature, 514, 247, 10.1038/nature13561 Downward, 2015, RAS synthetic lethal screens revisited: still seeking the elusive prize?, Clin. Cancer Res., 21, 1802, 10.1158/1078-0432.CCR-14-2180 Elenbaas, 2001, Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells, Genes Dev., 15, 50, 10.1101/gad.828901 Fan, 2005, Working set selection using second order information for training support vector machines, J. Mach. Learn. Res., 6, 1889 Feng, 2008, Computing and displaying isosurfaces in R, J. Stat. Softw., 28, 1 Flaherty, 2010, Inhibition of mutated, activated BRAF in metastatic melanoma, N. Engl. J. Med., 363, 809, 10.1056/NEJMoa1002011 Fultz, 2014 Garnett, 2012, Systematic identification of genomic markers of drug sensitivity in cancer cells, Nature, 483, 570, 10.1038/nature11005 Garraway, 2013, Lessons from the cancer genome, Cell, 153, 17, 10.1016/j.cell.2013.03.002 Good, 1985, Weight of evidence: a brief survey, Bayesian Stat., 2, 249 Groger, 2012, Meta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression, PLoS One, 7, e51136, 10.1371/journal.pone.0051136 Hartigan, 1975, Clustering algorithms, Vol. 2, 419 Hinata, 2003, Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin, Oncogene, 22, 1955, 10.1038/sj.onc.1206198 Hoadley, 2014, Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin, Cell, 158, 929, 10.1016/j.cell.2014.06.049 Hofmann-Wellenhof, B., Lichtenegger, H. & Wasle, E. (2007). GNSS – Global Navigation Satellite Systems – GPS, GLONASS, Galileo, etc. Hopewell, 2013, Lung tumor NF-kappaB signaling promotes T cell-mediated immune surveillance, J. Clin. Invest., 123, 2509, 10.1172/JCI67250 Hyman, 2015, Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations, N. Engl. J. Med., 373, 726, 10.1056/NEJMoa1502309 Jané-Valbuena, 2010, An oncogenic role for ETV1 in melanoma, Cancer Res., 70, 2075, 10.1158/0008-5472.CAN-09-3092 Joe, 1989, Relative entropy measures of multivariate dependence, J. Am. Stat. Assoc., 84, 157, 10.1080/01621459.1989.10478751 Kim, 2016, Characterizing genomic alterations in cancer by complementary functional associations, Nat. Biotechnol., 34, 539, 10.1038/nbt.3527 Kirzin, 2014, Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study, PLoS One, 9, e103159, 10.1371/journal.pone.0103159 Konieczkowski, 2014, A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors, Cancer Discov., 4, 816, 10.1158/2159-8290.CD-13-0424 Kwak, 2010, Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer, N. Engl. J. Med., 363, 1693, 10.1056/NEJMoa1006448 Liberzon, 2015, The Molecular Signatures Database (MSigDB) hallmark gene set collection, Cell Syst., 1, 417, 10.1016/j.cels.2015.12.004 Liberzon, 2011, Molecular Signatures Database (MSigDB) 3.0, Bioinformatics, 27, 1739, 10.1093/bioinformatics/btr260 Lin, 1991, Divergence measures based on the Shannon entropy, IEEE Trans. Inform. Theor., 37, 145, 10.1109/18.61115 Linfoot, 1957, An informational measure of correlation, Inf. Control, 1, 85, 10.1016/S0019-9958(57)90116-X Lundberg, 2002, Immortalization and transformation of primary human airway epithelial cells by gene transfer, Oncogene, 21, 4577, 10.1038/sj.onc.1205550 Lynch, 2004, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib, N. Engl. J. Med., 350, 2129, 10.1056/NEJMoa040938 Manchado, 2016, A combinatorial strategy for treating KRAS-mutant lung cancer, Nature, 534, 647, 10.1038/nature18600 McKenna, 2010, The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data, Genome Res., 20, 1297, 10.1101/gr.107524.110 Monti, 2003, Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data, Machine Learn., 52, 91, 10.1023/A:1023949509487 Mozina, 2004, Nomograms for visualization of naive Bayesian classifier, Lect. Notes Comput. Sci., 3202, 337, 10.1007/978-3-540-30116-5_32 Peck, 2006, A method for high-throughput gene expression signature analysis, Genome Biol., 7, R61, 10.1186/gb-2006-7-7-r61 Pott, 2015, What are super-enhancers?, Nat. Genet., 47, 8, 10.1038/ng.3167 Prahallad, 2012, Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR, Nature, 483, 100, 10.1038/nature10868 Pratilas, 2009, (V600E)BRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway, Proc. Natl. Acad. Sci. USA, 106, 4519, 10.1073/pnas.0900780106 Salt, 2014, Epithelial-to-mesenchymal transition rewires the molecular path to PI3K-dependent proliferation, Cancer Discov., 4, 186, 10.1158/2159-8290.CD-13-0520 Scott, 1997, 1 Seashore-Ludlow, 2015, Harnessing connectivity in a large-scale small-molecule sensitivity dataset, Cancer Discov., 5, 1210, 10.1158/2159-8290.CD-15-0235 Seo, 2012, The transcriptional landscape and mutational profile of lung adenocarcinoma, Genome Res., 22, 2109, 10.1101/gr.145144.112 Serresi, 2016, Polycomb repressive complex 2 is a barrier to KRAS-driven inflammation and epithelial-mesenchymal transition in non-small-cell lung cancer, Cancer Cell, 29, 17, 10.1016/j.ccell.2015.12.006 Sethna, 2011, 376 Shao, 2014, KRAS and YAP1 converge to regulate EMT and tumor survival, Cell, 158, 171, 10.1016/j.cell.2014.06.004 Sheather, 2004, Density estimation, Stat. Sci., 19, 588, 10.1214/088342304000000297 Singh, 2009, A gene expression signature associated with “K-Ras addiction” reveals regulators of EMT and tumor cell survival, Cancer Cell, 15, 489, 10.1016/j.ccr.2009.03.022 Singh, 2012, TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers, Cell, 148, 639, 10.1016/j.cell.2011.12.033 Skoulidis, 2015, Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities, Cancer Discov., 5, 860, 10.1158/2159-8290.CD-14-1236 Sun, 2014, Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3, Cell Rep., 7, 86, 10.1016/j.celrep.2014.02.045 Tamayo, 2011, Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features, J. Clin. Oncol., 29, 1415, 10.1200/JCO.2010.28.1675 Tamayo, 2007, Metagene projection for cross-platform, cross-species characterization of global transcriptional states, Proc. Natl. Acad. Sci. USA, 104, 5959, 10.1073/pnas.0701068104 Taube, 2010, Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes, Proc. Natl. Acad. Sci. USA, 107, 15449, 10.1073/pnas.1004900107 Tirosh, 2016, Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq, Science, 352, 189, 10.1126/science.aad0501 Torres-García, 2014, PRADA: pipeline for RNA sequencing data analysis, Bioinformatics, 30, 2224, 10.1093/bioinformatics/btu169 Venables, 2002, 868 Wood, 2012, MicroSCALE screening reveals genetic modifiers of therapeutic response in melanoma, Sci. Signal., 5, rs4, 10.1126/scisignal.2002612 Yang, 2013, Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells, Nucleic Acids Res., 41, D955 Ying, 2012, Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism, Cell, 149, 656, 10.1016/j.cell.2012.01.058 Zhu, 2014, Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit, Cancer Discov., 4, 452, 10.1158/2159-8290.CD-13-0646